HARROW, INC. — Director's Dealing 2013

May 8, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2013-04-01

Reporting Person: Boll Andrew (VP ACCOUNTING AND REPORTING)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-01	OPTION RIGHT TO BUY	$6	A	90000	Acquired	2023-04-01	COMMON STOCK (90000)	Direct

Footnotes

F1: Represents stock options granted under the Issuer's 2007 Stock Incentive and Awards Plan. The stock options vest in equal quarterly installments over a three year period.